We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Current CEO of Xylome, formerly with Amgen, Cubist and Novo Nordisk. Tom has a 35+year career bringing biopharmaceuticals to market at large and startup biopharmaceutical companies. He was the lead inventor of the current commercial Cubicin commercial process, a $1.2billion/yr antibiotic of last resort, which was approved in 2003.
This speaker's sessions: